The management of walking impairment and fatigue may be appropriate for improving physical health-related quality of life among Black and White people with multiple sclerosis.
Head rotation (HR) negatively affects balance and walking performance in people with multiple sclerosis (MS). Specifically, during walking, individuals with MS lose their walking rhythm for a few steps after HR, which represents a significant performance decline and may partly explain their increased risk of falling.
Unsolicited reports of the wearing-off effect related to ocrelizumab were infrequent (< 2%).
There is insufficient bone health risk assessment, screening, and management; there is also an absence of health care and lifestyle self-management information about the risk and prevention of poor bone health for people with multiple sclerosis.